Cargando…
4512 Allopregnanolone Dose Finding for Status Epilepticus Treatment by Pharmacokinetic-Pharmacodynamic Modeling using Quantitative EEG in Dogs
OBJECTIVES/GOALS: Allopregnanolone (ALLO), a modulator of GABA(A) receptors, may be useful as a treatment for human and canine benzodiazepine-refractory status epilepticus (SE). Our objective was to develop a phamacokinetic-pharmacodynamic (PKPD) model relating ALLO plasma concentrations to electroe...
Autores principales: | Patterson, Edward “Ned”, Vuu, Irene, Zolkowska, Dorota, Wu, Chun-Yi, Leppik, Ilo, Worrell, Greg, Kremen, Vaclav, Cloyd, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823320/ http://dx.doi.org/10.1017/cts.2020.51 |
Ejemplares similares
-
Intravenous Topiramate: Pharmacokinetics in Dogs with Naturally Occurring Epilepsy
por: Vuu, Irene, et al.
Publicado: (2016) -
Tolerability and pharmacokinetics of intravenous allopregnanolone with and without midazolam pretreatment in two healthy dogs
por: Bruun, Donald A., et al.
Publicado: (2023) -
Intranasal Allopregnanolone Confers Rapid Seizure Protection: Evidence for Direct Nose-to-Brain Delivery
por: Zolkowska, Dorota, et al.
Publicado: (2021) -
Allopregnanolone Preclinical Acute Pharmacokinetic and Pharmacodynamic Studies to Predict Tolerability and Efficacy for Alzheimer’s Disease
por: Irwin, Ronald W., et al.
Publicado: (2015) -
Correction: Allopregnanolone Preclinical Acute Pharmacokinetic and Pharmacodynamic Studies to Predict Tolerability and Efficacy for Alzheimer's Disease
Publicado: (2015)